ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, announced today that David Esposito, president and chief executive officer, will present a corporate update at the BIO CEO & Investor Conference on Tuesday, February 27 at 2:30 PM ET. The conference is taking place February 26-27, 2024, at the New York Marriott Marquis in New York City.
Mr. Esposito will also be available for one-on-one meetings with conference attendees. Those interested in scheduling a meeting may do so by contacting ONL’s company contact at the email below.